SAR Sareum Holdings plc

0.1909USD14.50 GBp · LSE-1.36%Mkt Cap: 31.28M USDP/E: —

Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a T…

Key Statistics

Company
Market Cap31.28M USD
Enterprise Value23.02M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-5.84M USD
Revenue/Share—
Last Price0.1909 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees5
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINGB00BMC3RJ87
Valuation
P/E (Trailing)—
P/E (Forward)-0.08
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B16.11
EPS (TTM)-0.03 USD
EPS (Forward)-2.39 USD
52W Range
0.154710% of range0.5267
52W High0.5267 USD
52W Low0.1547 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-194.91%
ROA-104.92%
ROIC—
ROCE-148.53%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.36M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-3.95%
Net Debt-3.28M USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio1.58
Quick Ratio1.58
Book Value/Sh0.01 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMar 1, 2022
Analyst Consensus
Rating—
Target (Mean)0.4609 USD
Upside (mean)+141.4%
Target Range0.4609 USD – 0.4609 USD
# Analysts1
Ownership
Shares Out.163.82M
Float133.49M
Insiders3.31%
Institutions0.00%
Technical
SMA 500.2758 (-30.8%)
SMA 2000.2812 (-32.1%)
Beta-0.53
S&P 52W Chg12.00%
Avg Vol (30d)298.07K
Avg Vol (10d)225.19K
Technical Indicators
RSI (14)15.7
MACD-2.8029
MACD Signal-3.1981
MACD Hist.+0.3951
BB Upper0.2818 USD
BB Middle0.2064 USD
BB Lower0.1310 USD
BB Width73.10%
ATR (14)0.0158 USD
Vol Ratio (20d)0.31x

About Sareum Holdings (LON: SAR)

›

Sareum Holdings (LON: SAR) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 5 employees.

The shares were at 14.50 GBp on 19 November 2026, up 3.6% over 52 weeks. Its 52-week range is 11.75 GBp to 40.00 GBp: the price is 63.7% below the high and 23.4% above the low.

Its market capitalisation is 23.75M GBP.

Sareum Holdings reports return on equity of -194.9% and an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 2.49M GBP. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 35.00 GBp is 141.4% above the current price.